Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 3Vaginitis 1Urologic Neoplasms 1Urologic Diseases 1Sexuality 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Hypogonadism 1Dyspareunia 1Castration-Resistant Prostate Carcinoma 1

Interventions

Psychiatric Rehabilitation 5Counseling 4Surveys and Questionnaires 2Sildenafil Citrate 2methyl N-acetylsibirosaminide 1exemestane 1black cohosh root extract 1Therapeutics 1Testosterone Propionate 1Testosterone 1Tamoxifen 1Sexual Health 1Restraint, Physical 1Radiotherapy 1Prostatectomy 1Pilocarpine 1Phentolamine 1Papaverine 1Oncology Nursing 1Mental Status and Dementia Tests 1High-Energy Shock Waves 1Educational Status 1Diet Therapy 1Aromatase Inhibitors 1Arginine 1ArginMax 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sexuality × Testosterone Propionate × Clear all
NCT00075855 2016-07-13

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Alliance for Clinical Trials in Oncology

Phase 3 Completed
150 enrolled
Other

Sexual Dysfunction, Physiological, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡